|
Parameters
| | | |
|---|
|
Oncotype DX Risk Category
|
Low (< 18)
|
Intermediate (> 18, ≤30)
|
High(> 30)
|
|---|
|
No. of Patients (N = 125)
|
66 (53%)
|
44 (35%)
|
15 (12%)
|
|
Age
|
20–77
|
25–70
|
45–70
|
|
Sex
|
|
Female
|
66 (53%)
|
43 (34%)
|
15 (12%)
|
|
Male
|
0 (0%)
|
1 (1%)
|
0 (0%)
|
|
Patient Ethnicity
|
|
White
|
33 (26%)
|
23 (18%)
|
5 (5%)
|
|
African American
|
3 (2%)
|
2 (2%)
|
2 (2%)
|
|
Asian
|
1 (1%)
|
2 (2%)
|
1 (1%)
|
|
Unknown
|
22 (18%)
|
17 (14%)
|
7(6%)
|
|
PR Status
|
|
Positive
|
64 (51%)
|
39 (31%)
|
10 (8%)
|
|
Negative
|
2 (2%)
|
3 (2%)
|
5 (4%)
|
|
Unknown
|
0 (0%)
|
2 (2%)
|
0 (0%)
|
|
HER2 Status
|
|
Positive
|
0 (0%)
|
1 (1%)
|
0 (0%)
|
|
Negative
|
66 (53%)
|
42 (34%)
|
15 (12%)
|
|
Unknown
|
0 (0%)
|
1 (1%)
|
0 (0%)
|
|
Histologic Tumor Grade
|
|
Low (4, 5)
|
10 (8%)
|
14 (11%)
|
0 (0%)
|
|
Moderate (6, 7)
|
48 (38%)
|
24 (19%)
|
4 (3%)
|
|
High (8, 9)
|
8 (6%)
|
6 (5%)
|
11 (9%)
|
|
Tumor Type
|
|
Ductal
|
53 (42%)
|
37 (30%)
|
14 (11%)
|
|
Ductal With Lobular Features
|
9 (7%)
|
3 (2%)
|
1 (1%)
|
|
Ductal with Mucinous Features
|
1 (1%)
|
2 (2%)
|
0 (0%)
|
|
Mixed
|
3 (2%)
|
2 (2%)
|
0 (0%)
|
